MP29-03 is simple prostatectomy after prior minimally invasive surgical therapies for benign prostatic hyperplasia as efficacious as primary simple prostatectomy
Abstract
INTRODUCTION AND OBJECTIVE: Robotic simple prostatectomy (RSP) is indicated in patients with enlarged glands (>80 grams) who present with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). Salvage simple prostatectomy (SSP) is defined as any RSP performed for management of LUTS after failure of prior transurethral procedures. The aim of this study is to evaluate the efficacy of primary simple prostatectomy (PSP) versus SSP in ameliorating LUTS. METHODS: We retrospectively reviewed 117 patients who underwent RSP between 2013 and 2021. Indications for surgery were prostate glands (> 80g), bothersome LUTS, or symptoms refractory to medical management and/or previous prostate surgery. PSP and SSP preoperative patient characteristics, perioperative variables, and postoperative outcomes were recorded for comparison. The severity of LUTS was assessed using the International Prostate Symptom Score (IPSS). Two-tailed Student's t-tests were performed to compare primary vs. salvage RSP cohorts at a p-value (p) of 0.05. RESULTS: Of 117 patients who underwent RSP, 95 were primary and 22 were in the salvage setting with 15 undergoing prior TURP, 3 status post TUMT, 1 status post vaporization, 1 status post nodal ablation, and 2 status post UroLIFT. Mean length of stay following RSP was 1.91 (days). At mean follow up 12.26 (months), none of the patients required re-operation for LUTS. Preoperative IPSS for primary and salvage RSP was 18.69 and 17.31,…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.